Li Chen,Lichun Feng,Yun He,Mengwei Huang,Hongying Yun
申请号：
US12959408
公开号：
US08354443B2
申请日:
2010.12.03
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates to a compound of formula (I)as well as pharmaceutically acceptable salt thereof, wherein R1 to R4 have the significance given in claim 1. The compound may be used, for example, for the treatment or prophylaxis of obesity, hyperglycemia, dyslipidemia, and type 1 or type 2 diabetes.
